Immunopathogenesis of Lysosomal Disorders and Presumptive Role in SARS-CoV-2 Severity

Renuka Limgala, PhD, of the Lysosomal & Rare Disorders Research & Treatment Center (LDRTC) explains the immunopathogenesis of lysosomal disorders and how that may play a presumptive role in SARS-CoV-2 severity.  

This presentation was part the GRIDS 2020-Virtual Summit held July 1, 2020 and is available exclusively on CheckRare. 

To view the entire session and receive CME credit, go to https://checkrare.com/learning/p-grids2020-module3-lysosomal-disease-pathophysiology-and-covid-19/